Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 418.69 Million USD | -2.13% |
| 2022 | 427.81 Million USD | 189.6% |
| 2021 | 147.72 Million USD | 538.54% |
| 2020 | 23.13 Million USD | 193.29% |
| 2019 | 7.88 Million USD | 1326.4% |
| 2018 | 553 Thousand USD | 20.22% |
| 2017 | 460 Thousand USD | -20.96% |
| 2016 | 582 Thousand USD | -0.34% |
| 2015 | 584 Thousand USD | -36.93% |
| 2014 | 926 Thousand USD | -29.53% |
| 2013 | 1.31 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 100.0% |
| 2010 | -1.97 Million USD | 11.78% |
| 2009 | -2.24 Million USD | 54.31% |
| 2008 | -4.9 Million USD | 12.27% |
| 2007 | -5.59 Million USD | -71.67% |
| 2006 | -3.25 Million USD | -121.78% |
| 2005 | -1.46 Million USD | -76.35% |
| 2004 | -833 Thousand USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 419.26 Million USD | 0.14% |
| 2024 Q2 | 419.84 Million USD | 0.14% |
| 2023 Q4 | 418.69 Million USD | 0.14% |
| 2023 Q3 | 418.12 Million USD | -2.22% |
| 2023 Q2 | 427.63 Million USD | -0.01% |
| 2023 Q1 | 427.66 Million USD | -0.03% |
| 2023 FY | 418.69 Million USD | -2.13% |
| 2022 Q1 | 148.14 Million USD | 0.29% |
| 2022 Q2 | 312.22 Million USD | 110.75% |
| 2022 Q3 | 311.89 Million USD | -0.1% |
| 2022 Q4 | 427.81 Million USD | 37.16% |
| 2022 FY | 427.81 Million USD | 189.6% |
| 2021 Q3 | 148.47 Million USD | -0.02% |
| 2021 FY | 147.72 Million USD | 538.54% |
| 2021 Q4 | 147.72 Million USD | -0.5% |
| 2021 Q1 | 149.83 Million USD | 547.63% |
| 2021 Q2 | 148.5 Million USD | -0.88% |
| 2020 Q2 | 13.41 Million USD | 160.46% |
| 2020 Q4 | 23.13 Million USD | -2.24% |
| 2020 Q1 | 5.14 Million USD | -34.72% |
| 2020 FY | 23.13 Million USD | 193.29% |
| 2020 Q3 | 23.66 Million USD | 76.45% |
| 2019 Q4 | 7.88 Million USD | 0.0% |
| 2019 Q3 | 7.88 Million USD | 0.0% |
| 2019 Q2 | 7.88 Million USD | 1.66% |
| 2019 Q1 | 7.75 Million USD | 1303.07% |
| 2019 FY | 7.88 Million USD | 1326.4% |
| 2018 Q1 | 583 Thousand USD | 26.74% |
| 2018 Q3 | 640 Thousand USD | -3.76% |
| 2018 Q4 | 553 Thousand USD | -13.59% |
| 2018 FY | 553 Thousand USD | 20.22% |
| 2018 Q2 | 665 Thousand USD | 14.07% |
| 2017 Q2 | 604 Thousand USD | 6.9% |
| 2017 Q4 | 460 Thousand USD | -8.91% |
| 2017 FY | 460 Thousand USD | -20.96% |
| 2017 Q1 | 565 Thousand USD | -2.92% |
| 2017 Q3 | 505 Thousand USD | -16.39% |
| 2016 Q2 | 587 Thousand USD | 15.78% |
| 2016 FY | 582 Thousand USD | -0.34% |
| 2016 Q4 | 582 Thousand USD | -2.51% |
| 2016 Q3 | 597 Thousand USD | 1.7% |
| 2016 Q1 | 507 Thousand USD | -13.18% |
| 2015 FY | 584 Thousand USD | -36.93% |
| 2015 Q1 | 798 Thousand USD | -13.82% |
| 2015 Q2 | 699 Thousand USD | -12.41% |
| 2015 Q3 | 538 Thousand USD | -23.03% |
| 2015 Q4 | 584 Thousand USD | 8.55% |
| 2014 Q2 | 1.14 Million USD | -4.92% |
| 2014 FY | 926 Thousand USD | -29.53% |
| 2014 Q4 | 926 Thousand USD | -10.01% |
| 2014 Q3 | 1.02 Million USD | -9.82% |
| 2014 Q1 | 1.2 Million USD | -8.68% |
| 2013 FY | 1.31 Million USD | 0.0% |
| 2013 Q1 | 1.44 Million USD | 12.5% |
| 2013 Q3 | 1.35 Million USD | -2.38% |
| 2013 Q2 | 1.38 Million USD | -4.35% |
| 2013 Q4 | 1.31 Million USD | -2.88% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | 1.28 Million USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 100.0% |
| 2011 Q1 | - USD | 100.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 FY | -1.97 Million USD | 11.78% |
| 2010 Q3 | -2.07 Million USD | -1.72% |
| 2010 Q4 | -1.97 Million USD | 4.44% |
| 2010 Q2 | -2.03 Million USD | 4.33% |
| 2010 Q1 | -2.12 Million USD | 5.13% |
| 2009 Q3 | -2.43 Million USD | 18.18% |
| 2009 Q4 | -2.24 Million USD | 7.74% |
| 2009 Q1 | -3.07 Million USD | 37.25% |
| 2009 Q2 | -2.97 Million USD | 3.54% |
| 2009 FY | -2.24 Million USD | 54.31% |
| 2008 FY | -4.9 Million USD | 12.27% |
| 2008 Q3 | -5.65 Million USD | 4.06% |
| 2008 Q4 | -4.9 Million USD | 13.18% |
| 2008 Q2 | -5.89 Million USD | -2.43% |
| 2008 Q1 | -5.75 Million USD | -2.82% |
| 2007 Q3 | -4.42 Million USD | -16.89% |
| 2007 Q4 | -5.59 Million USD | -26.28% |
| 2007 Q2 | -3.78 Million USD | 0.0% |
| 2007 Q1 | - USD | 100.0% |
| 2007 FY | -5.59 Million USD | -71.67% |
| 2006 FY | -3.25 Million USD | -121.78% |
| 2006 Q2 | -1.74 Million USD | -4.5% |
| 2006 Q4 | -3.25 Million USD | -45.32% |
| 2006 Q1 | -1.66 Million USD | -13.55% |
| 2006 Q3 | -2.24 Million USD | -28.63% |
| 2005 Q2 | -958 Thousand USD | -14.73% |
| 2005 Q4 | -1.46 Million USD | -27.08% |
| 2005 FY | -1.46 Million USD | -76.35% |
| 2005 Q1 | -835 Thousand USD | -0.24% |
| 2005 Q3 | -1.15 Million USD | -20.67% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | -833 Thousand USD | 0.0% |
| 2004 FY | -833 Thousand USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -1059.756% |
| BrainsWay Ltd. | 239 Thousand USD | -175086.192% |
| Cerus Corporation | 59.79 Million USD | -600.206% |
| Envoy Medical, Inc. | 404 Thousand USD | -103537.376% |
| electroCore, Inc. | 537 Thousand USD | -77869.274% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -3489025.0% |
| IceCure Medical Ltd | 376 Thousand USD | -111255.053% |
| Inogen, Inc. | 18.27 Million USD | -2191.708% |
| OrthoPediatrics Corp. | 13.45 Million USD | -3010.892% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -210299.497% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -115013.383% |
| MaxCyte, Inc. | 17.96 Million USD | -2230.096% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -757252.941% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | -349.692% |
| PAVmed Inc | 2.96 Million USD | -14045.101% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -6637.93% |
| RxSight, Inc. | 1.21 Million USD | -34474.319% |
| Sight Sciences, Inc. | 31.7 Million USD | -1220.471% |
| SI-BONE, Inc. | 36.06 Million USD | -1060.946% |
| TELA Bio, Inc. | 40.51 Million USD | -933.432% |
| Treace Medical Concepts, Inc. | 53 Million USD | -689.871% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -27427.613% |
| Acutus Medical, Inc. | 32.65 Million USD | -1182.217% |
| Talis Biomedical Corporation | 16.78 Million USD | -2394.311% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -10250.927% |
| CVRx, Inc. | 30.38 Million USD | -1278.102% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -41072.45% |
| Bioventus Inc. | 366.99 Million USD | -14.086% |
| Venus Concept Inc. | 70.79 Million USD | -491.461% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -33557.154% |
| LivaNova PLC | 568.54 Million USD | 26.356% |
| 908 Devices Inc. | 3.92 Million USD | -10556.528% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 18.069% |
| Nemaura Medical Inc. | 3.08 Million USD | -13460.308% |
| NeuroPace, Inc. | 56.95 Million USD | -635.146% |
| LENSAR, Inc. | 1.75 Million USD | -23825.429% |
| Apyx Medical Corporation | 33.18 Million USD | -1161.7% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -2683.136% |
| BioSig Technologies, Inc. | 103 Thousand USD | -406400.0% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -1456.256% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -4108.413% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 71.805% |
| Axonics, Inc. | 25.84 Million USD | -1520.337% |
| Outset Medical, Inc. | 134.59 Million USD | -211.078% |
| IRIDEX Corporation | 1.75 Million USD | -23811.765% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | -715.55% |
| IRadimed Corporation | 1.61 Million USD | -25824.103% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -237794.886% |
| INVO Bioscience, Inc. | 6.77 Million USD | -6079.009% |
| Telesis Bio, Inc. | 5.26 Million USD | -7846.385% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -6911.8% |
| Varex Imaging Corporation | 464.2 Million USD | 9.803% |
| Quipt Home Medical Corp. | 60.82 Million USD | -588.404% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -71106.633% |
| Pulmonx Corporation | 35.08 Million USD | -1093.237% |
| Dynatronics Corporation | 3.25 Million USD | -12749.404% |
| Modular Medical, Inc. | 817 Thousand USD | -51147.858% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -277181.457% |
| Semler Scientific, Inc. | 70 Thousand USD | -598035.714% |
| InMode Ltd. | 6.61 Million USD | -6231.393% |
| Bruker Corporation | 1.14 Billion USD | 63.417% |
| Cytosorbents Corporation | 2.54 Million USD | -16365.535% |
| DexCom, Inc. | 2.57 Billion USD | 83.727% |
| Align Technology, Inc. | 96.96 Million USD | -331.787% |
| Viveve Medical, Inc. | 5.12 Million USD | -8071.253% |
| ZimVie Inc. | 508.79 Million USD | 17.709% |
| Movano Inc. | 15.00 USD | -2791299900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -2210.041% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | -5.04% |
| Profound Medical Corp. | 4.97 Million USD | -8316.965% |
| Insulet Corporation | 1.36 Billion USD | 69.358% |
| enVVeno Medical Corporation | 1.06 Million USD | -39251.034% |
| Surmodics, Inc. | 29.4 Million USD | -1323.89% |
| iCAD, Inc. | 273 Thousand USD | -153268.132% |
| Nuwellis, Inc. | 221 Thousand USD | -189354.751% |
| Biotricity, Inc. | 10.85 Million USD | -3756.867% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -1097.983% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -64339.301% |
| InspireMD, Inc. | 1.03 Million USD | -40236.705% |
| PAVmed Inc. | 2.96 Million USD | -14045.101% |
| BIOLASE, Inc. | 13.98 Million USD | -2893.886% |
| Beyond Air, Inc. | 14.72 Million USD | -2744.202% |
| FONAR Corporation | 37.92 Million USD | -1003.88% |
| AxoGen, Inc. | 46.6 Million USD | -798.429% |
| Vivani Medical, Inc. | 19.31 Million USD | -2067.944% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | -838.526% |
| Inari Medical, Inc. | 30.35 Million USD | -1279.328% |
| UFP Technologies, Inc. | 28 Million USD | -1395.339% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -96363.5% |
| Tenon Medical, Inc. | 428 Thousand USD | -97725.935% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -41685.928% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -19354.46% |
| AdaptHealth Corp. | 2.09 Billion USD | 80.011% |
| Sintx Technologies, Inc. | 3.68 Million USD | -11255.98% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | -1024.829% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -71106.633% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -70150.839% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 53.074% |
| TransMedics Group, Inc. | 506.2 Million USD | 17.287% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -68877.759% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -452616.657% |
| Hyperfine, Inc. | 64 Thousand USD | -654110.938% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | -121.838% |
| Biomerica, Inc. | 459 Thousand USD | -91118.954% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -93050.353% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -220280.868% |
| Silk Road Medical, Inc | 75.62 Million USD | -453.639% |